FDA Device Intelligence
Home › ABBOTT MOLECULAR INC. › UroVysion

UroVysion

ABBOTT MOLECULAR INC. · Model 02J27-011 · UDI-DI 00884999002128

OYU Prescription
3
510(k) clearances
4
Adverse events
1
Recalls
2
Facilities

Description

ProbeChek UroVysion Bladder Cancer Kit Control Slides

Recalls

DateFirmReason
2024-02-01Abbott Molecular, Inc.Products that were intended for export only which were not approved or registered in accordance with U.S. specifications were shipped to U.S. customers.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.